Healthcare provider profile · identity verified

Gene Royer

Family Practice · PORTER, ME · NPI 1992776017

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	623	169
Amlodipine Besylate	Amlodipine Besylate	493	136
Losartan Potassium	Losartan Potassium	409	112
Levothyroxine Sodium	Levothyroxine Sodium	328	80
Lisinopril	Lisinopril	321	91
Rosuvastatin Calcium	Rosuvastatin Calcium	247	69
Sertraline Hcl	Sertraline Hcl	216	62
Metformin Hcl	Metformin Hcl	210	58
Omeprazole	Omeprazole	205	60
Albuterol Sulfate Hfa	Albuterol Sulfate	197	57
Metoprolol Succinate	Metoprolol Succinate	193	57
Metoprolol Tartrate	Metoprolol Tartrate	149	41
Famotidine	Famotidine	141	40
Atenolol	Atenolol	126	33
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	120	13
Allopurinol	Allopurinol	113	34
Tamsulosin Hcl	Tamsulosin Hcl	110	33
Glipizide	Glipizide	104	27
Ozempic	Semaglutide	99	21
Simvastatin	Simvastatin	98	28
Pantoprazole Sodium	Pantoprazole Sodium	91	26
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	89	30
Gabapentin	Gabapentin	89	26
Jardiance	Empagliflozin	80	21
Fluticasone Propionate	Fluticasone Propionate	79	25
Terazosin Hcl	Terazosin Hcl	75	19
Trazodone Hcl	Trazodone Hcl	74	19
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	74	22
Hydrochlorothiazide	Hydrochlorothiazide	71	19
Alprazolam	Alprazolam	70	suppressed
Pravastatin Sodium	Pravastatin Sodium	64	17
Furosemide	Furosemide	62	21
Tramadol Hcl	Tramadol Hcl	62	11
Eliquis	Apixaban	55	17
Aripiprazole	Aripiprazole	54	11
Duloxetine Hcl	Duloxetine Hcl	54	14
Montelukast Sodium	Montelukast Sodium	53	16
Hydroxyzine Pamoate	Hydroxyzine Pamoate	51	18
Ezetimibe	Ezetimibe	49	15
Fluoxetine Hcl	Fluoxetine Hcl	48	13
Metformin Hcl Er	Metformin Hcl	48	13
Paroxetine Hcl	Paroxetine Hcl	45	13
Triamcinolone Acetonide	Triamcinolone Acetonide	45	26
Carvedilol	Carvedilol	44	12
Ibuprofen	Ibuprofen	43	12
Meloxicam	Meloxicam	43	12
Enalapril Maleate	Enalapril Maleate	41	11
Zolpidem Tartrate	Zolpidem Tartrate	41	suppressed
Celecoxib	Celecoxib	40	14
Clonazepam	Clonazepam	40	suppressed
Xarelto	Rivaroxaban	40	12
Prednisone	Prednisone	39	24
Ropinirole Hcl	Ropinirole Hcl	39	11
Januvia	Sitagliptin Phosphate	38	suppressed
Topiramate	Topiramate	38	suppressed
Buspirone Hcl	Buspirone Hcl	36	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	35	suppressed
Alendronate Sodium	Alendronate Sodium	34	suppressed
Sucralfate	Sucralfate	34	suppressed
Chlorthalidone	Chlorthalidone	33	suppressed
Finasteride	Finasteride	33	12
Lorazepam	Lorazepam	33	suppressed
Lovastatin	Lovastatin	33	suppressed
Pregabalin	Pregabalin	33	suppressed
Tizanidine Hcl	Tizanidine Hcl	31	suppressed
Donepezil Hcl	Donepezil Hcl	30	11
Glipizide Er	Glipizide	29	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	29	11
Azithromycin	Azithromycin	27	22
Citalopram Hbr	Citalopram Hydrobromide	27	suppressed
Methadone Hcl	Methadone Hcl	27	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	26	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	26	suppressed
Oxycodone Hcl	Oxycodone Hcl	25	suppressed
Potassium Chloride	Potassium Chloride	24	suppressed
Testosterone Cypionate	Testosterone Cypionate	24	suppressed
Oxycontin	Oxycodone Hcl	23	suppressed
Symbicort	Budesonide/Formoterol Fumarate	23	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	23	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	22	suppressed
Spironolactone	Spironolactone	22	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	21	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	21	suppressed
Ketoconazole	Ketoconazole	21	suppressed
Synthroid	Levothyroxine Sodium	21	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	19	16
Warfarin Sodium	Warfarin Sodium	19	suppressed
Baclofen	Baclofen	18	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	18	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	18	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	18	suppressed
Jantoven	Warfarin Sodium	18	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	18	suppressed
Clopidogrel	Clopidogrel Bisulfate	17	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	17	suppressed
Novolog Flexpen	Insulin Aspart	17	suppressed
Trulicity	Dulaglutide	17	suppressed
Bumetanide	Bumetanide	16	suppressed
Bupropion Xl	Bupropion Hcl	16	suppressed
Diazepam	Diazepam	16	suppressed
Divalproex Sodium	Divalproex Sodium	16	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	16	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	16	suppressed
Fluconazole	Fluconazole	15	12
Methocarbamol	Methocarbamol	15	suppressed
Propranolol Hcl	Propranolol Hcl	15	suppressed
Tresiba Flextouch U-100	Insulin Degludec	15	suppressed
Diclofenac Sodium	Diclofenac Sodium	14	suppressed
Mounjaro	Tirzepatide	14	suppressed
Trihexyphenidyl Hcl	Trihexyphenidyl Hcl	14	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	14	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	13	suppressed
Carbamazepine	Carbamazepine	13	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	12	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	12	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Repaglinide	Repaglinide	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Valsartan	Valsartan	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	suppressed
Atrovent Hfa	Ipratropium Bromide	11	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	11	suppressed
Methylphenidate Er	Methylphenidate Hcl	11	suppressed
Spiriva Respimat	Tiotropium Bromide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error